Thermo Fisher Scientific Supports Program to Accelerate COVID Variant Identification
Thermo Fisher Scientific will help develop a new genotyping method for SARS-CoV-2 that could speed up the identification of new variants.
Read MorePosted by Andy Lundin | Mar 24, 2022 | Covid 19 |
Thermo Fisher Scientific will help develop a new genotyping method for SARS-CoV-2 that could speed up the identification of new variants.
Read MorePosted by Andy Lundin | Mar 23, 2022 | Allergy & Autoimmune |
Antiphospholipid syndrome in children is often not identified until destructive clotting has already occurred.
Read MorePosted by Andy Lundin | Mar 22, 2022 | Covid 19, Immunoassay Reagents & test Kits |
The research was motivated by urgent needs early in the pandemic to increase testing amid shortages of supplies, notably nasal swabs.
Read MorePosted by Andy Lundin | Mar 21, 2022 | Cancer |
The study aims to enables access to comprehensive genetic and genomic testing for advanced cancer patients in underserved communities.
Read MorePosted by Andy Lundin | Mar 18, 2022 | Covid 19 |
Researchers have developed a PCR test that uses molecular beacons to diagnose a COVID-19 infection and the variant causing the infection.
Read More